Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsPregabalin capsules

    Pregabalin Capsules

    Jump to

    • Lupin receives FDA approval for Generic LYRICA

      Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received final approval for its Pregabalin Capsules from the United States Food and Drugs Administration to market a generic version of C.P. Pharmaceuticals C.V., LYRICA® (Pregabalin) capsules.

    • Lupin gets tentative USFDA approval for Pregabalin capsules

      Drug-maker Lupin today said it has received tentative approval from the US health regulator to market Pregabalin capsules, used in the treatment of chronic pain as a result from an injury to the nervous system, in the American market.

    • Lupin gets tentative US FDA nod for anti-epilepsy drug

      Pharma major Lupin’s US subsidiary has got tentative approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for Pregabalin Capsules, used for treating pain caused by neurologic diseases and seizures.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347